Assertio Holdings

ASRT · NASDAQ

Price unavailable right now.

No price history for this range.

Latest news

Press releaseJun 16, 4:30 PM ETBusiness Wire
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
Press releaseJun 9, 1:19 PM ETPRNewswire
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
Press releaseMay 25, 4:13 PM ETPRNewswire
Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?
Press releaseMay 22, 4:42 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate the Merger--ASRT, SILA, KW, and UNF
Press releaseMay 19, 6:24 PM ETPRNewswire
Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?
Press releaseMay 19, 2:08 PM ETBusiness Wire
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
Press releaseMay 13, 11:44 AM ETPRNewswire
Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders
Press releaseMay 13, 8:00 AM ETBusiness Wire
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
Press releaseMay 8, 8:00 AM ETBusiness Wire
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
Press releaseMay 5, 9:00 AM ETBusiness Wire
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
Press releaseMay 4, 8:00 AM ETBusiness Wire
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
Press releaseApr 29, 4:30 PM ETBusiness Wire
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
Press releaseApr 21, 5:00 PM ETBusiness Wire
Assertio Provides Update on Garda Therapeutics Tender Process
Press releaseApr 15, 3:09 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WSR, ASRT, EHAB, and SEM
Press releaseApr 14, 10:58 AM ETPRNewswire
Are AVNS, LEG, ASRT Obtaining Fair Deals for their Shareholders?
Press releaseApr 13, 10:36 PM ETBusiness Wire
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
Press releaseApr 13, 9:09 AM ETBusiness Wire
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
Press releaseApr 9, 1:13 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)
Press releaseApr 8, 4:10 PM ETBusiness Wire
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
Press releaseApr 8, 4:04 PM ETBusiness Wire
Assertio Announces Agreement to be Acquired by Garda Therapeutics
NewsMar 24, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsMar 16, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseMar 16, 4:05 PM ETBusiness Wire
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
NewsMar 16, 7:11 AM ET
Earnings Scheduled For March 16, 2026
Press releaseMar 3, 4:30 PM ETBusiness Wire
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Press releaseJan 12, 4:15 PM ETBusiness Wire
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
Press releaseJan 9, 1:45 PM ETBusiness Wire
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
Press releaseDec 22, 4:30 PM ETBusiness Wire
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
NewsNov 12, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsNov 10, 4:14 PM ET
Assertio Holdings Q3 Adj. EPS $0.18 Beats $(0.09) Estimate, Sales $49.459M Beat $27.020M Estimate
Press releaseNov 10, 4:13 PM ETBusiness Wire
Assertio Reports Third Quarter 2025 Financial Results
NewsNov 10, 6:12 AM ET
Earnings Scheduled For November 10, 2025
NewsNov 7, 1:05 PM ET
Earnings Outlook For Assertio Holdings
Press releaseAug 11, 4:05 PM ETGlobe Newswire
Assertio Reports Second Quarter 2025 Financial Results
Press releaseMay 12, 4:01 PM ETGlobe Newswire
Assertio Reports First Quarter 2025 Financial Results
Press releaseMar 12, 4:05 PM ETGlobe Newswire
Assertio Reports Fourth Quarter and Full Year 2024 Financial Results
Press releaseDec 6, 7:00 AM ETGlobe Newswire
Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer
Press releaseNov 11, 4:02 PM ETGlobe Newswire
Assertio Reports Third Quarter 2024 Financial Results
NewsJul 10, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027

Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?

$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate the Merger--ASRT, SILA, KW, and UNF

Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?

Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders

Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer

Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics

Assertio and Garda Mutually Agree to Extend Tender Offer Deadline

Assertio Provides Update on Garda Therapeutics Tender Process

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--WSR, ASRT, EHAB, and SEM

Are AVNS, LEG, ASRT Obtaining Fair Deals for their Shareholders?

Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT

ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)

Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio

Assertio Announces Agreement to be Acquired by Garda Therapeutics

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session

Assertio Reports Fourth Quarter and Full Year 2025 Financial Results

Earnings Scheduled For March 16, 2026

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Assertio Holdings Q3 Adj. EPS $0.18 Beats $(0.09) Estimate, Sales $49.459M Beat $27.020M Estimate

Assertio Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 10, 2025

Earnings Outlook For Assertio Holdings

Assertio Reports Second Quarter 2025 Financial Results

Assertio Reports First Quarter 2025 Financial Results

Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

Assertio Reports Third Quarter 2024 Financial Results

10 Health Care Stocks Whale Activity In Today's Session